China Stories: The Budding Market for Microscopic Organ Testing

‘Organoid-on-a-chip’ has already been used to evaluate Covid vaccine efficacy in China, but a lack of regulation means the uptake of the niche technology is lagging behind the West. Click here to read the Caixin Global article. Subscribe to a bundle deal now to unlock all coverage by Caixin Global and The Wall Street Journal for only $250 a year. It’s a 60% discount.